The Pasteur Museum is housed in the apartment where Louis Pasteur spent his final seven years and offers a rare behind-the-scenes look at the living and working environment of the world-renowned scientist. Visitors can gain a unique insight into his everyday life alongside his wife and can admire his rich and diverse scientific work.
The Institut Pasteur’s scientific strategy focuses on developing original and innovative topics and promoting interdisciplinary and multidisciplinary cooperation and approaches. The Institut Pasteur teams have access to the technological resources needed to speed up and further improve the quality of their outstanding research.
Ever since the introduction of the world’s first "Technical Microbiology" course in 1889, teaching has been a priority for the Institut Pasteur. The Institut Pasteur has an international reputation for quality teaching that attracts students from all over the world who come to further their training or top up their degree programs.
The mission of the Industrial Partnership team is to detect, promote, assist and protect the inventive activities from research (inventions, know-how and biological materials) conducted at the Institut Pasteur (and in some Institutes of its international network), and transfer there to industrial and/or institutional partners, in order to serve the patient needs and for the benefit of the society, as well as to contribute to sustainability of the Institut Pasteur’s resources.
With international courses, PhD and postdoctoral traineeship, each institute of the Institut Pasteur International Network (RIIP) contributes to the transmission of knowledge with the training of young researchers all around the world. In this context, doctoral and postdoctoral programmes, study and traineeship fellowships are available to scientists. Alongside training, dynamism and attractiveness of RIIP will result in the creation of 4-year group for the young researchers.
Transmissibility of new coronavirus too low to trigger global epidemic at this stage
In a study published online on July 5, 2013 for the medical journal The Lancet, a team from the Institut Pasteur suggests that the coronavirus MERS-CoV, in its current form, is not capable of triggering a global epidemic. However, it should not be assumed that the virus’ transmissibility will not increase if the virus mutates or if transmission occurs at a one-off event where large numbers of people are gathered. Because of this, scientists emphasize the importance of identifying the animal reservoir for the virus in order to stop transmission to humans and the importance of continued monitoring, worldwide, of suspected cases in order to diagnose, treat, and isolate new patients as quickly as possible.
Paris, May 29, 2013
The Middle East Respiratory Syndrome coronavirus (MERS-CoV) is a respiratory virus that belongs to the same family as the SARS coronavirus which struck in 2003. Infection by the MERS-CoV causes respiratory distress with a high mortality rate (around 60%). The victims affected by this virus tend to suffer from pre-existing chronic diseases or are immunodeficient. Never before seen in humans, today MERS-CoV is considered as an emerging virus. The first confirmed case of infection was in April 2012 in Jordan. Since then 64 cases of MERS-CoV infection have been documented (as of June 21, 2013).
In a study published July 5, 2013, the Epidemiology of Emerging Diseases Unit at the Institut Pasteur in Paris, led by Arnaud Fontanet (epidemiologist and professor at the CNAM), estimates the pandemic risk of the MERS-CoV. By drawing on the analysis of known cases within the literature, the scientists indicate that the virus, in its current form, has not yet reached pandemic potential.
Romulus Breban, a scientist within the research unit, reached this conclusion by calculating the basic reproduction number of the virus; it represents the number of secondary infections resulting from each infected patient. In their most pessimistic scenario this number was estimated at 0.69. In order to have epidemic potential the number must be at least 1.0 (meaning that each infected patient leads to more than one secondary infection). This data was compared with the basic reproduction number of prepandemic SARS, which was 0.8. While the figures may be close (0.69 and 0.8) the pandemic risk for the new coronavirus is not as apparent: “both viruses share similarities on clinical, epidemiological, and virological levels, but they have distinct biology, for example using different surface receptors on human cells”, explains Arnaud Fontanet. Moreover, the spread of MERS-CoV is slower than that of SARS. While the latter mutated into a highly infectious form (in humans) within a matter of months, the MERS-CoV has been present for over a year and has yet to mutate into a pandemic form.
However, the scientists stress that the reproduction number of the virus may increase if the virus mutates or if transmission occurs at a one-off event where large numbers of people are gathered. In order to avoid another SARS, the scientists recommend implementing the necessary means to stop the virus progression before it reaches pandemic potential. This is why identifying the animal reservoir for MERS-CoV is crucial to stopping transmission to humans as is the need for continued monitoring, worldwide, of suspected cases in order to diagnose, treat, and isolate new patients as quickly as possible.
Illustration - Copyright Institut Pasteur
Caption – Viral particle of MERS-CoV observed using electron microscopy.